NP Life Sciences Health Industry Group Inc.
ACAT· OTC
Filed Nov 22, 2021 · 10-Q · 53 days after period end · 0001493152-21-029587
| Metric | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|
| Revenue | — | $0.00 | $0.00 |
| Net Income | -$20.83K | -$25.64K | -$31.88K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 22, 2021 · 53 d after period end